SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : The thread of life -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (50)11/3/2000 1:56:11 PM
From: Extra PaleRespond to of 1336
 
Rick,

Frustrating part about these biobuck deals is trying to assign some semblance of economic value plus get a feel for management negotiating skills and strategy. Did gzmo trade low milestones for relatively larger royalty? Does gzmo have a feasible strategy in selling antigens? What is potential royalty stream from SAGE? I listened into related conference calls and heard, IMHO, little relevance in analyst questions. Anyway, thanks for the insightful comments; this is an interesting learning process.



To: scaram(o)uche who wrote (50)11/6/2000 12:02:08 PM
From: Mike McFarlandRead Replies (1) | Respond to of 1336
 
Thanks Rick!
In other news...MCDE has backed off its predictable
ICAAC rally to around $15, sort of returned to the very
slowly rising trendline at $9.

I've bought my shares back.

Kurt Jarnagin
Alan Roter

What a nice press release, pushed all the right radio
buttons on my Etrade screen.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News